Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
International Journal of Rheumatic Diseases
|
February 17, 2017
Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study
Paul Bird, Dave Nicholls, Rina Barrett, et al.
International Journal of Rheumatic Diseases
|
June 4, 2014
Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis
Bethan L Richards, Samuel Whittle, Rachelle Buchbinder, et al.
Clinical Rheumatology
|
November 26, 2021
Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset
Kathleen Tymms, Belinda E Butcher, Tracey L Sletten, et al.
The Journal of Rheumatology
|
July 3, 2015
Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study
Geoffrey Littlejohn, Lynden Roberts, Paul Bird, et al.
Rheumatology and Therapy
|
January 5, 2025
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
Clinical Rheumatology
|
March 8, 2024
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher, et al.
Rheumatology and Therapy
|
September 13, 2025
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
International Journal of Rheumatology
|
June 21, 2017
The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice
Lynden Roberts, Kathleen Tymms, Julien de Jager, et al.
International Journal of Rheumatic Diseases
|
February 5, 2025
The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset
Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
ACR Open Rheumatology
|
June 12, 2023
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set
Sabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
International Journal of Rheumatic Diseases
|
February 17, 2017
Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study
Paul Bird, Dave Nicholls, Rina Barrett, et al.
International Journal of Rheumatic Diseases
|
June 4, 2014
Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis
Bethan L Richards, Samuel Whittle, Rachelle Buchbinder, et al.
Clinical Rheumatology
|
November 26, 2021
Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset
Kathleen Tymms, Belinda E Butcher, Tracey L Sletten, et al.
The Journal of Rheumatology
|
July 3, 2015
Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study
Geoffrey Littlejohn, Lynden Roberts, Paul Bird, et al.
Rheumatology and Therapy
|
January 5, 2025
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
Clinical Rheumatology
|
March 8, 2024
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher, et al.
Rheumatology and Therapy
|
September 13, 2025
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
International Journal of Rheumatology
|
June 21, 2017
The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice
Lynden Roberts, Kathleen Tymms, Julien de Jager, et al.
International Journal of Rheumatic Diseases
|
February 5, 2025
The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset
Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
ACR Open Rheumatology
|
June 12, 2023
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set
Sabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, et al.
Page
of 5